Clinical Trial Update: Efficacy and Safety of An'Ningpai Expectorant in Non-CF Bronchiectasis [Phase 4]

View source ↗

Summary

Clinical trial update on the efficacy and safety of An'Ningpai Expectorant in adults with bronchiectasis (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• An'Ningpai Expectorant

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Bronchiectasis Adult | Phase 4 | Status: UNKNOWN